Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$35.7

Avg closing price
Price range

12 Joel Greenblatt Mirati Therapeutics Trades

The first Mirati Therapeutics trade was made in Q1 2019. Since then Joel Greenblatt bought shares five more times and sold shares on six occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Mirati Therapeutics anymore.

Avg closing price
Price range
Sold -10.7 Thousand shares Q4 2023
Avg closing price $56.22
Price range $41.99 - $62.38
New holding (+10.7 Thousand shares) Q3 2023
Avg closing price $35.70
Price range $27.80 - $45.35
Sold -1.58 Thousand shares Q1 2022
Avg closing price $102.26
Price range $75.82 - $150.97
Increased shares by 8.7% (+126 shares) Q4 2021
Avg closing price $155.26
Price range $132.01 - $190.29
Sold 23.7% shares (-452 shares) Q3 2021
Avg closing price $160.88
Price range $132.13 - $177.45
Increased shares by 26.0% (+393 shares) Q2 2021
Avg closing price $160.56
Price range $144.00 - $179.73
New holding (+1.51 Thousand shares) Q3 2020
Avg closing price $136.84
Price range $113.26 - $167.27
Sold -1.93 Thousand shares Q1 2020
Avg closing price $89.68
Price range $69.78 - $116.21
New holding (+1.93 Thousand shares) Q4 2019
Avg closing price $96.45
Price range $70.76 - $128.86
Sold -3.41 Thousand shares Q3 2019
Avg closing price $93.85
Price range $77.91 - $109.60
Sold 11.8% shares (-458 shares) Q2 2019
Avg closing price $77.85
Price range $59.49 - $104.71
New holding (+3.87 Thousand shares) Q1 2019
Avg closing price $68.03
Price range $43.65 - $78.95

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!